Anda di halaman 1dari 9

TataChemicals

Overseassubsidiarydisappoints;cashflowstoremainstressed
PhillipCapital (India) Pvt. Ltd.
11February2013
FERTILISER:QuarterlyUpdate
Results disappoint: Tata Chemicals topline has been inline with estimates;
howeverEbitdadisappointedsignificantly(almostbyabout18%).Keyreasonsfor
divergenceare1/largestquarterlylossofRs620mninBMGLsubsidiary(thisis
despite consolidation of British salt) and 2/lower than estimated profits in
domestic fertilizers. Unfavorable prices/cost pressures in Africa and lower
demandintheUKhalvedmargins qoqto7%.AsaresultoverallEbitdadegrew
19%qoqtoRs5.1bn.Thelongtermforexrevaluationfurtherstressedtheweak
EbitdabyaboutRs810mn.ThefallinEbitdawaslargelymadeupbyhigherother
income(inclRs1.3bnonaccountofforexgains;adjforcomparison)andlower
tax;whichcurtailedfurtherfallinreportedPATtoRs2.24bn(degrew13%qoq).
However,theadj.PATofRs1.33bn,degrew40%qoq;muchbelowourest.
BMGLand domesticfertilizer; marginwoesenlarged in Q3:Domesticfertilizer
division continues to be under stress; with overall Ebitda/mt at Rs 2247/mt
against average of 8 qtr avg of Rs 2,700/mt; a fall of about 20%. We expect in
P&K, Tata Chem to have earned wafer thin margins of about US$ 20~25/mt.
Furtherexpensivefeedandunfavourablerealizations,pressuredAfricasodaash
operations and that of UK has been under stress due to stiff competition. We
dontseethewoesforthetwinassetsreversinganytimesoon.
Q3review&outlookofkeybusinessesacrossgeography
Tata Chem (domestic): Weak INR and easing feed costs helped post 8% gr in
chemical EBIT qoq. Fertiliser margins were pressured by weak P&K margins.
HelpedbyweakINR,weexpectchem.marginstoremainhealthyinthenearterm
BMGL: Cost pressures, stiff competition, weather related uncertainty could
continuetoexertpressureonoperations/results
GCIP:Withutilizationratesalreadyat97%;thegrowthseemstobetaperingoff.
Likely lower realizations in FY14% (down by 2~3%) and likely increase in
feedcosts (shale gas prices expected to rise) we expect margins to remain
subdued.WealsohighlightmarginsforGCIPhavecomeofffrom30%inQ2FY12
toabout24%atpresent.WeexpectEbitdatolikelyshrinkthanrise
IMACID:Onalowerbase,weexpectresultstoimprovebutbelikelysubdued
Rallis:Competition,costpressuresonaweakdemandbackgroundhavehardhit
thenumbers,weexpectmarginstoimprovesomewhatinFY14E
Others:LossesincreasedfromRs37mntoRs170mnqoq
Cut estimates, downgrade to Neutral: We cut our estimates significantly going
by 1/muted growth in GCIP 2/persisting margin pressures (for P&K) and
lengthened working capital cycle led by delayed subsidy reimbursements and
3/no firm timelines on addressing operational issues in BMGL. While volumes
couldpullbackinH1FY14E;thesustenanceofmarginsremainsuncertain.Wesee
heightened need for cash, given scheduled debt repayments, capex funding
(Babrala,TripuraandGabonUreaprojects)andlengthenedworkingcapitalcycle
followingdelayedsubsidyreimbursementsfromthegovernment.Thisdoesraise
prospectsofmonetizinginvestments(mktvalueoflistedinvtisRs40/sh;valueof
unlistedinvestmentcouldalmostequalitscurrentdebtofRs70bn)inbridging
the resource deficit. However, considering the nearterm headwinds that cloud
earningsoutlook,wedowngradeourratingtoNeutralandlowerPTtoRs385(Rs
400earlier).

DowngradetoNeutral
TTCHIN|CMPRS355
TARGETRS385(+9%)

CompanyData
O/SSHARES(MN):
MARKETCAP(RSBN):
MARKETCAP(USDBN):
52WKHI/LO(RS):
LIQUIDITY3M(USDMN):
FACEVALUE(RS):

255
90
1.7
382/299
4.3
10

ShareHoldingPattern,%
PROMOTERS:
FII/NRI:
FI/MF:
NONPROMOTERCORP.HOLDINGS:
PUBLIC&OTHERS:

31.1
15.9
28.5
3.0
21.6

PricePerformance,%
ABS
RELTOBSE

1mth
5.7
4.3

3mth
11.2
7.8

1yr
2.4
7.6

PriceVs.Sensex(Rebasedvalues)

140

120

100

80
Apr10 Jan11 Oct11 Jul12
TataChem
BSESensex

Source:PhillipCapitalIndiaResearch
OtherKeyRatios
Rsmn
FY12 FY13E
FY14E
NetSales
136,551 153,111 153,396
EBITDA
21,527 18,856 21,956
NetProfit
8,376 3,931
7,773
EPS,Rs
32.9
34.3
35.1
PER,X
10.8
11.5
10.1
EV/EBIDTA,x
6.4
8.2
6.7
EV/NetSales,x
1.0
1.0
1.0
ROE,%
13.2
12.2
11.5
Source:PhillipCapitalIndiaResearchEst.

GauriAnand(+912266679943)
ganand@phillipcapital.in

SaurabhRathi(+912266679951)
srathi@phillipcapital.in

11February2013/INDIAEQUITYRESEARCH/TATACHEMICALSQUARTERLYUPDATE

Quarterlyresults
Rsmn
NetSales
(Inc)/Decinstock
As%ofSales
RawMaterialConsumed
As%ofSales
Costoftradedgoods
As%ofSales
EmployeeExpenses
As%ofSales
Power&Fuel
As%ofSales
Freight&forwardingcharges
As%ofSales
OtherExpenses
As%ofSales
TotalExpenditure
EBITDA
EBIDTA%
Depreciation
EBIT
EBIT%
Interestexpenses
Exceptionalitems
OtherIncome
PBT
TotalTax
Taxrate%
PAT
ShareofProfitsinAssoc
Minorityint
RPAT
APAT

OPM%
NPM%
AEPS

Q2FY13
41,655
(2,221)
5
11,027
26
8,656
21
2,811
7
4,063
10
4,308
10
6,709
16
35,353
6,303
15
1402
4,901
12
1144
124
760
4,393
1158
26
3,235
1
667
2,568
2,253

15.1
5.4
8.8

Q3FY12
37,939
(222)
1
12,365
33
5,243
14
2,535
7
3,793
10
3,553
9
3,989
11
32,541
5,398
14
1228
4,170
11
1111
468
613
3,204
645
20
2,559
22
300
2,238
2,441

Q3FY13
41,705
2,918
7
13,356
32
2,943
7
2,796
7
4,529
11
4,157
10
5,908
14
36,606
5,099
12
1378
3,721
9
1184
813
1730
3,454
733
21
2,722
8
473
2,241
1,331

14.2
6.4
9.6

12.2
3.2
5.2

Source:Company,PhillipCapitalIndiaResearch

2of9

yoy%
9.9
1417.2

8.0

43.9

10.3

19.4

17.0

48.1

12.5
5.5

QoQ%
0.1
231.4

21.1

66.0

0.5

11.5

3.5

11.9

3.5
19.1

12.2
10.8

1.7
24.1

6.6
73.6
182.2
7.8
13.6

3.5
558.2
127.5
21.4
36.8

6.3
62.4
57.8
0.1
45.5

15.9
1540.0
29.1
12.7
40.9

45.5

40.9

9MFY12
102,574
5,732
6
31,721
31
17,055
17
7,085
7
10,697
10
9,984
10
11,167
11
85,781
16,793

3,727
13,066
13
3,062
1,017
2,224
11,211
2,636
24
8,574
22
1,560
6,992
7,080

16.4
6.9
27.8

9MFY13
113,569
1,266
1
30,627
27
14,109
12
8,415
7
12,208
11
12,196
11
18,852
17
97,672
15,897

yoy%
10.7
122.1

4,147
11,749
10
3,572
1,553
3,326
9,950
2,341
24
7,609
20
1,705
5,884
5,660

11.3
10.1

9.3
15.8
20.1

14.0
5.0
22.2

20.0

3.4
17.3
18.8
14.1
22.2
68.8
13.9
5.3

16.7
52.6
49.5
11.2
11.2
11.3

11February2013/INDIAEQUITYRESEARCH/TATACHEMICALSQUARTERLYUPDATE

TataChems30.6%stakeinEPMMiningisvaluedatRs8bnorRs32/sh
EPMMining(EPM)EPMisaUS$200mnmarketcapcompanyfocusedondevelopinga
premiumspecialtypotashfertilizer(namedSulfateofPotash)inUtah,USA.Itclaimsto
control102,000acresofbrinedepositwitharesourcepotentialof100mmtatdepthof
only 300 feet. According to EPM, its likely to be on of the lowest cost producer as it
wouldprocessnaturalSOPbysolarevaporationmethod.GiventhenaturalSOP(priced
atUS$675/mt)isatabout40%premiumtoMOP(pricedatUS$475/mt),theprofitsare
likelytobemuchhigher.

EPMhascommenceddrillingandawaits43101filingforresourceconfirmationwhichit
hasfiledthismonth.EPMexpectstaxbreaksfortheprojectongroundsthatitwouldbe
abletogenerateemployment,notwithstandingthetaxbenefitsitestimatesNPVofUS$
527 mn (10% discount rate) with commercial production in 2016. Tata Chem has
invested about Rs 800 mn (US$ 16 mn) for 30.6% stake in EPM Mining. We work the
valueofTataChemsinvestmentinEPMMiningatUS$158mnorRs8bn.

AboutSOPSulfateofPotash(SOP)isapremiumproductforchloridesensitivecrops.
Thisisahighvaluefertilizerthathasworldwidedemandofmorethan6mmtandisused
mainly on high value specialty crops like Citrus fruits, Strawberries, Peaches, some
vegetables,tobaccoandcotton.
EPMminingdetails
NameoftheProduct
ResourceEstimate
EPMMIniingMarketCap
Estimatedrealisation/costs
MOP
SOP
Costofproduction
EstRevin2016
EstEbitdain2016
ProjectedNAV(@10%discount)
TataChem'sholding
inEPMMining
inEPMMining
Investedamount
ValueinEPM(30.6%stake)

inmmt
US$mn

$/mt
$/mt
$/mt
US$mn
US$mn
US$mn

mnsh
%stake
US$mn
US$mn

SulfateofPotash
100
200

Source:EPMMiningVenturesInc.Presentation

DerivationofPriceTargetDeepValue
FigsinRs.Mn.
Fert&Chembusiness
InvestmentsQuoted
Investmentsunquoted
Valueoffirm
Add:CashFY14E
Less:DebtFY14E
Enterprisevalue
TargetPriceRs.
CMPRs.
Upsidefromcurrentlevels%

FY14E
142,712
9,680
2,586
154,978
5,028
61,339
98,667
385
355
9

Source:Company,PhillipCapitalIndiaResearch

3of9

Comments
Valuedat6.5xfY14Eebitda
quotedinvtassumedat30%discounttocmp

30%stakeinepmmining

475
675
130
621
276
527
37
30.60%
16
158

11February2013/INDIAEQUITYRESEARCH/TATACHEMICALSQUARTERLYUPDATE

Segmentalbreakup
Rsmn
Revenues
InorganicChemicals
Fertilisers
OtherAgriInputs(Rallis)
Others
Total
Less:Intersegmentrevenue
Netsales/incomefromoperations

EBIT
InorganicChemicals
Fertilisers
OtherAgriInputs(Rallis)
Others
Total

As%ofSales
InorganicChemicals
Fertilisers
OtherAgriInputs(Rallis)
Others

PBIT%
InorganicChemicals
Fertilisers
OtherAgriInputs(Rallis)
Others

As%ofPBIT
InorganicChemicals
Fertilisers
OtherAgriInputs(Rallis)
Others

Q2FY13

19,102
17,229
5,378
257
41,966
311
41,655

3,278
1,663
998
(37)
5,902

45.9
41.4
12.9

17.2
9.7
18.6
14.5

55.5
28.2
16.9
0.6

Q3FY12

Q3FY13

yoy%

QoQ%

16,670
17,287
4,168
176
38,300
361
37,939

19,252
18,431
4,266
214
42,162
458
41,705

15.5
6.6
2.3
21.8
10.1
26.8
9.9

0.8
7.0
20.7
16.6
0.5
47.2
0.1

2,609 2,706
1,672 1,153
230
422
(254) (170)
4,257 4,110

3.7
31.0
82.9
33.2
3.4

17.5
30.7
57.8
356.5
30.4

43.9
45.6
11.0

46.2
44.2
10.2

15.6
9.7
5.5
144.7

14.1
6.3
9.9
79.3

61.3
39.3
5.4
6.0

65.8
28.1
10.3
4.1

Source:Company,PhillipCapitalIndiaResearch

4of9

9MFY12

48,237
41,916
12,757
527
103,437
862
102,574

9,229
4,110
1,629
556
14,413

47.0
40.9
12.4

19.1
9.8
12.8
105.5

64.0
28.5
11.3
3.9

9MFY13

yoy%

57,005
42,638
14,087
706
114,435
867
113,569

18.2
1.7
10.4
34.0
10.6
0.5
10.7

9,496
3,096
1,831
340
14,083

2.9
24.7
12.4
38.7
2.3

50.2
37.5
12.4

16.7
7.3
13.0
48.2

67.4
22.0
13.0
2.4

11February2013/INDIAEQUITYRESEARCH/TATACHEMICALSQUARTERLYUPDATE

TCL'sOverseasoperationalperformancereview

GCIP
NetSales(Rsmn)
EBIT(Rsmn)
EBIT%
SalesVolumes(000Mt)
RealisationRs/Mt
Re/USD
RealisationUS$/Mt
EBIT/Mt(INR)
EBIT/Mt(US$)
BMGL
NetSales(Rsmn)
EBIT(Rsmn)
EBIT%
SalesVolumes(000Mt)
RealisationRs/Mt
Re/USD
RealisationUS$/Mt
EBIT/Mt(INR)
EBIT/Mt(US$)
IMACID(Rsmn)
NetSales
EBIT
EBIT%
APAT

Q1FY13

Q2FY13

6,690
1,780
27
575
11,635
54.2
215
3,096
57

6,450
1,510
23
566
11,396
55.2
206
2,668
48

5,810
740
13
299
19431
54.2
358
2475
46

5,790
750
13
289
20035
55.2
363
2595
47

420
100
24
120

1,740
100
6
70

Q3FY13 Comments

6,900 Capacityexpansionssupportstoplinegr.
1,630 Improvesonalowerbase
24
629
10,970 Changeinproductmix;lowersrealisation
54.2
203
2,591
48

5,560 Revenuedegrewledbylowerrealisations
370 CostpressurespullsmarginsdowninKenya
7
288 Kenyaproductiondegrewalmost20%;howeverhigherinventoryhelpsreportsflatsalesvol.qoq
19306
54.2
357 Changeinproductmix;lowersrealisation
1285
24

2,030 Volumesimproveonalowerbase,howeverlowerrealisationshurttoplinegrowth
80
4
60

Source:Company,PhillipCapitalIndiaResearch

Operatingmarginsperformance(%)
TCL consl. EBIT margins

Salesvol.('000mt)
Fert. Div. margins

2,500

Chem. Div. margins

30.0

Soda Ash

Urea

DAP/NPK

Salt

2,000

20.0
10.0

1,500

0.0

1,000

-10.0
-20.0

500

-30.0

Q1FY09
Q2FY09
Q3FY09
Q4FY09
Q1FY10
Q2FY10
Q3FY10
Q4FY10
Q1FY11
Q2FY11
Q3FY11
Q4 FY11
Q1 FY12
Q2 FY12
Q3 FY12
Q4FY12
Q1 FY13
Q2 FY13
Q3 FY13
Source:Company,PhillipCapitalIndiaResearch

5of9

Q1FY09
Q2FY09
Q3FY09
Q4FY09
Q1FY10
Q2FY10
Q3FY10
Q4FY10
Q1FY11
Q2FY11
Q3FY11
Q4 FY11
Q1 FY12
Q2 FY12
Q3 FY12
Q4FY12
Q1 FY13
Q2 FY13
Q3 FY13

-40.0

11February2013/INDIAEQUITYRESEARCH/TATACHEMICALSQUARTERLYUPDATE

Financials

CashFlow

IncomeStatement
Y/EMar,Rsmn
Netsales
Growth,%
Totalincome
Operatingexpenses
EBITDA(Core)

FY12

FY13E

FY14E

FY15E

136,551

153,111

153,396

157,295

Pretaxprofit

23

12

136,551

153,111

153,396

157,295

115,024

134,254

131,440

134,883

21,527

18,856

21,956

22,412

Y/EMar,Rsmn

FY12

FY13E

FY14E

FY15E

13,834

9,982

11,994

13,309

Depreciation

5,087

5,521

5,457

5,557

Chginworkingcapital

4,719 20,168

322

403

Totaltaxpaid

3,808

3,423

3,765

Otheroperatingactivities

3,619

4,700

4,700

4,700

4,700

Growth,%

15.5(12.4)16.4 2.1

Cashflowfromoperatingactivities

15,094

3,585

19,051

19,400

Margin,%

15.8 12.314.3 14.2

5,921

Capitalexpenditure

9,619

7,890

5,184

Depreciation

5,087

5,521

5,457

5,557

Chgininvestments

1,618

EBIT

16,440

13,335

16,499

16,855

Cashflowfrominvestingactivities

11,236

7,890

5,184

5,921

Growth,%

15.5(12.4)16.4 2.1

Freecashflow

3,858 11,475

13,867

Margin,%

15.8 12.314.3 14.2

Debtraised/(repaid)

6,116

6,994

8,950

Interestpaid

4,270

5,740

5,674

4,715

OtherNonOperatingIncome

3,188

3,939

1,170

1,170

Dividend(incl.tax)

2,905

2,905

3,195

3,195

Otherfinancingactivities

9,930

9,930

9,930

9,930

Cashflowfromfinancingactivities

2,512

3,290 13,615 16,483

NonrecurringItems

1,524

1,553

Pretaxprofit

13,834

10,010

11,994

13,309

Netchgincash

Taxprovided

3,439

3,619

3,423

3,765

8,376

7,869

7,773

8,747

ValuationRatios&PerShareData

NetProfit
Growth,%

23.3 4.62.1 10.9

NetProfit(adjusted)

8,3768,7598,943 9,917

Unadj.shares(m)

255 255255 255

Wtdavgshares(m)

255 255255 255

BalanceSheet
Y/EMar,Rsmn

5,220

1,346 14,765

251

3,004

FY15E

FY12

FY13E

FY14E

EPS,Rs

32.9

34.3

35.2

34.3

BVPS,Rs

269.4

292.6

318.8

345.2

DPS,Rs

11.0

10.0

10.0

11.0

Returnonassets(%)

7.6

5.4

6.6

6.9

Returnonequity(%)

13.2

12.2

11.5

10.3

29.1

17.7

19.9

20.3

3.2

1.9

2.2

2.3

19.9

8.6

10.9

11.5
8.1

FY12

FY13E

FY14E

FY15E

ReturnonInvestedcapital(%)

Cash&bank

16,780

4,881

5,028

2,830

RoIC/Costofcapital(x)

Debtors

23,107

27,266

27,317

28,011

RoICCostofcapital(%)

Inventory

18,634

20,230

19,806

20,325

Returnoncapitalemployed(%)

9.4

6.6

7.8

8,555

8,555

8,555

8,555

Costofcapital(%)

9.2

9.1

9.0

8.9

67,076

60,932

60,706

59,722

RoCECostofcapital(%)

0.3

(2.6)

(1.2)

(0.8)

6,097

6,097

Loans&advances
Totalcurrentassets
Investments

6,097

6,097

Assetturnover(x)

2.5

2.3

1.9

2.0

Grossfixedassets

100,211 105,703 113,593

118,777

Sales/Totalassets(x)

0.8

0.8

0.8

0.9

Less:Depreciation

56,267

61,788

67,245

72,802

Sales/NetFA(x)

2.9

3.0

3.0

3.0

Add:CapitalWIP

5,492

7,890

5,184

5,921

Workingcapital/Sales(x)

0.1

0.2

0.2

0.2

Netfixedassets

49,436

51,805

51,532

51,896

Receivabledays

61.8

65.0

65.0

65.0

65,594

63,587

63,587

63,587

Inventorydays

49.8

48.2

47.1

47.2

189,546 183,765 183,266

182,645

Payabledays

46.6

50.0

50.0

50.0

Currentratio(x)

1.6

2.1

2.1

2.0

Noncurrentassets
Totalassets

Currentliabilities

42,943

29,002

28,722

29,301

Quickratio(x)

1.1

1.4

1.4

1.3

Provisions

15,439

12,962

13,190

13,422

Interestcover(x)

3.9

2.3

2.9

3.6

Totalcurrentliabilities

58,382

41,964

41,913

42,723

Dividendcover(x)

3.3

3.4

3.2

3.1

Noncurrentliabilities

64,131

69,351

62,357

53,407

PER(x)

10.8

11.5

10.1

9.1

122,513 111,314 104,270

96,130

Price/Book(x)

1.3

1.2

1.1

1.0

EV/EBIT(x)

6.4

8.2

6.7

6.2

Totalliabilities
Paidupcapital

2,548

2,548

2,548

2,548

Reserves&surplus

61,632

66,596

72,344

79,064

EV/NOPLAT(x)

7.6

10.1

7.9

7.5

Shareholdersequity

68,661

74,572

81,231

87,951

EV/CE

0.9

1.0

0.9

0.9

189,546 183,765 183,266

182,645

Totalequity&liabilities

Source:Company,PhillipCapitalIndiaResearchEstimates

6of9

11February2013/INDIAEQUITYRESEARCH/TATACHEMICALSQUARTERLYUPDATE

RecommendationHistory
Recommendation
Neutral
Buy
Buy
Neutral
Buy
Neutral
Neutral
Neutral

7of9

Target,Rs

CMP,Rs

385
400
428
400
450
375
340
287

355
307
363
351
390
349
305
258

Date
11/02/13
01/06/12
14/02/12
28/01/11
01/11/10
5/8/2010
2/2/2010
14/09/09

11February2013/INDIAEQUITYRESEARCH/TATACHEMICALSQUARTERLYUPDATE

Management
VineetBhatnagar(ManagingDirector)
SajidKhalid(HeadInstitutionalEquities)
JigneshShah(HeadEquityDerivatives)

(9122)23002999
(9122)66679972
(9122)66679735

Research
Automobiles,ITServices
DeepakJain
NehaGarg
VarunVijayan

Banking,NBFCs
ManishAgarwalla
SachitMotwani,FRM

Consumer,Media,Telecom
NaveenKulkarni,CFA,FRM
EnnetteFernandes
VivekanandSubbaraman

Cement
VaibhavAgarwal

(9122)66679758
(9122)66679996
(9122)66679992

(9122)66679962
(9122)66679953

(9122)66679947
(9122)66679764
(9122)66679766

(9122)66679967

Economics
AnjaliVerma

Engineering,CapitalGoods
AnkurSharma
JisharThoombath

Metals
DhawalDoshi
DharmeshShah

Infrastructure
VibhorSinghal
RaheelArathodi

Oil&Gas,Fertiliser
GauriAnand
SaurabhRathi

(9122)66679943
(9122)66679951

SunilKamath(SalesTrader)
ChetanSavla(SalesTrader)
RajeshAshar(SalesTrader)

(9122)66679747
(9122)66679745
(9122)66679746

(9122)66679969

(9122)66679759
(9122)66679986

(9122)66679769
(9122)66679974

(9122)66679949
(9122)66679768

Retail,RealEstate
AbhishekRanganathan,CFA
NehaGarg

Midcaps
KapilBagaria
RaheelArathodi

Technicals&Quant
NeppolianPillai
ShikhaKhurana

Sr.ManagerEquitiesSupport
RosieFerns

(9122)66679952
(9122)66679996

(9122)66679965
(9122)66679768

(9122)66679989
(9122)66679948

(9122)66679971

Sales&Distribution
KinshukTiwari
PawanKakumanu
ShubhangiAgrawal
DipeshSohani

(9122)66679946
(9122)66679934
(9122)66679964
(9122)66679756

MayurShah(Execution)
GurudattUchil(Execution)

(9122)66679945
(9122)66679750

SINGAPORE
PhillipSecuritiesPteLtd
250NorthBridgeRoad,#0600RafflesCityTower,
Singapore179101
Tel:(65)65336001Fax:(65)65353834
www.phillip.com.sg

ContactInformation(RegionalMemberCompanies)

MALAYSIA
PhillipCapitalManagementSdnBhd
B36BlockBLevel3,MeganAvenueII,
No.12,JalanYapKwanSeng,50450KualaLumpur
Tel(60)321628841Fax(60)321665099
www.poems.com.my

HONGKONG
PhillipSecurities(HK)Ltd
11/FUnitedCentre95QueenswayHongKong
Tel(852)22776600Fax:(852)28685307
www.phillip.com.hk

JAPAN
PhillipSecuritiesJapan,Ltd
42NihonbashiKabutocho,Chuoku
Tokyo1030026
Tel:(81)336662101Fax:(81)336640141
www.phillip.co.jp

INDONESIA
PTPhillipSecuritiesIndonesia
ANZTowerLevel23B,JlJendSudirmanKav33A,
Jakarta10220,Indonesia
Tel(62)2157900800Fax:(62)2157900809
www.phillip.co.id

CHINA
PhillipFinancialAdvisory(Shanghai)Co.Ltd.
No550YanAnEastRoad,OceanTowerUnit2318
Shanghai200001
Tel(86)2151699200Fax:(86)2163512940
www.phillip.com.cn

THAILAND
PhillipSecurities(Thailand)PublicCo.Ltd.
15thFloor,VorawatBuilding,849SilomRoad,
Silom,Bangrak,Bangkok10500Thailand
Tel(66)222680999Fax:(66)222680921
www.phillip.co.th

FRANCE
King&ShaxsonCapitalLtd.
3rdFloor,35RuedelaBienfaisance
75008ParisFrance
Tel(33)145633100Fax:(33)145636017
www.kingandshaxson.com

UNITEDKINGDOM
King&ShaxsonLtd.
6thFloor,CandlewickHouse,120CannonStreet
London,EC4N6AS
Tel(44)2079295300Fax:(44)2072836835
www.kingandshaxson.com

UNITEDSTATES
PhillipFuturesInc.
141WJacksonBlvdSte3050
TheChicagoBoardofTradeBuilding
Chicago,IL60604USA
Tel(1)3123569000Fax:(1)3123569005

AUSTRALIA
PhillipCapitalAustralia
Level37,530CollinsStreet
Melbourne,Victoria3000,Australia
Tel:(61)396298380Fax:(61)396148309
www.phillipcapital.com.au

SRILANKA
AshaPhillipSecuritiesLimited
Level4,MillenniumHouse,46/58NavamMawatha,
Colombo2,SriLanka
Tel:(94)112429100Fax:(94)112429199
www.ashaphillip.net/home.htm

INDIA
PhillipCapital(India)PrivateLimited
No.1,CBlock,2ndFloor,ModernCenter,JacobCircle,K.K.Marg,MahalaxmiMumbai400011
Tel:(9122)23002999Fax:(9122)66679955www.phillipcapital.in

8of9

11February2013/INDIAEQUITYRESEARCH/TATACHEMICALSQUARTERLYUPDATE

DisclosuresandDisclaimers

PhillipCapital (India) Pvt. Ltd. has three independent equity research groups: Institutional Equities, Institutional Equity Derivatives and Private Client Group. This
reporthasbeenpreparedbyInstitutionalEquitiesGroup.Theviewsandopinionsexpressedinthisdocumentmayormaynotmatchormaybecontraryattimes
withtheviews,estimates,rating,targetpriceoftheotherequityresearchgroupsofPhillipCapital(India)Pvt.Ltd.

ThisreportisissuedbyPhillipCapital(India)Pvt.Ltd.whichisregulatedbySEBI.PhillipCapital(India)Pvt.Ltd.isasubsidiaryofPhillip(Mauritius)Pvt.Ltd.References
to"PCIPL"inthisreportshallmeanPhillipCapital(India)Pvt.Ltdunlessotherwisestated.ThisreportispreparedanddistributedbyPCIPLforinformationpurposes
onlyandneithertheinformationcontainedhereinnoranyopinionexpressedshouldbeconstruedordeemedtobeconstruedassolicitationorasofferingadvicefor
thepurposesofthepurchaseorsaleofanysecurity,investmentorderivatives.TheinformationandopinionscontainedintheReportwereconsideredbyPCIPLtobe
validwhenpublished.ThereportalsocontainsinformationprovidedtoPCIPLbythirdparties.Thesourceofsuchinformationwillusuallybedisclosedinthereport.
WhilstPCIPLhastakenallreasonablestepstoensurethatthisinformationiscorrect,PCIPLdoesnotofferanywarrantyastotheaccuracyorcompletenessofsuch
information.AnypersonplacingrelianceonthereporttoundertaketradingdoessoentirelyathisorherownriskandPCIPLdoesnotacceptanyliabilityasaresult.
Securities and Derivatives markets may be subject to rapid and unexpected price movements and past performance is not necessarily an indication to future
performance.

Thisreportdoesnothaveregardtothespecificinvestmentobjectives,financialsituationandtheparticularneedsofanyspecificpersonwhomayreceivethisreport.
Investorsmustundertakeindependentanalysiswiththeirownlegal,taxandfinancialadvisorsandreachtheirownregardingtheappropriatenessofinvestinginany
securitiesorinvestmentstrategiesdiscussedorrecommendedinthisreportandshouldunderstandthatstatementsregardingfutureprospectsmaynotberealized.
InnocircumstancesitbeusedorconsideredasanoffertosellorasolicitationofanyoffertobuyorselltheSecuritiesmentionedinit.Theinformationcontainedin
theresearchreportsmayhavebeentakenfromtradeandstatisticalservicesandothersources,whichwebelievearereliable.PhillipCapital(India)Pvt.Ltd.oranyof
its group/associate/affiliate companies do not guarantee that such information is accurate or complete and it should not be relied upon as such. Any opinions
expressedreflectjudgmentsatthisdateandaresubjecttochangewithoutnotice

Important:Thesedisclosuresanddisclaimersmustbereadinconjunctionwiththeresearchreportofwhichitformspart.Receiptanduseoftheresearchreportis
subjecttoallaspectsofthesedisclosuresanddisclaimers.Additionalinformationabouttheissuersandsecuritiesdiscussedinthisresearchreportisavailableon
request.

Certifications: The research analyst(s) who prepared this research report hereby certifies that the views expressed in this research report accurately reflect the
researchanalystspersonalviewsaboutallofthesubjectissuersand/orsecurities,thattheanalysthavenoknownconflictofinterestandnopartoftheresearch
analysts compensationwas,isorwill be,directly orindirectly,relatedtothe specific views orrecommendationscontainedinthis researchreport.TheResearch
Analystcertifiesthathe/sheorhis/herfamilymembersdoesnotownthestock(s)coveredinthisresearchreport.

Independence:PhillipCapital(India)Pvt.Ltd.hasnothadaninvestmentbankingrelationshipwith,andhasnotreceivedanycompensationforinvestmentbanking
servicesfrom,thesubjectissuersinthepasttwelve(12)months,andPhillipCapital(India)Pvt.Ltddoesnotanticipatereceivingorintendtoseekcompensationfor
investmentbankingservicesfromthesubjectissuersinthenextthree(3)months.PhillipCapital(India)Pvt.Ltdisnotamarketmakerinthesecuritiesmentionedin
thisresearchreport,althoughitoritsaffiliatesmayholdeitherlongorshortpositionsinsuchsecurities.PhillipCapital(India)Pvt.Ltddoesnotholdmorethan1%of
thesharesofthecompany(ies)coveredinthisreport.

SuitabilityandRisks:Thisresearchreportisforinformationalpurposesonlyandisnottailoredtothespecificinvestmentobjectives,financialsituationorparticular
requirementsofanyindividualrecipienthereof.Certainsecuritiesmaygiverisetosubstantialrisksandmaynotbesuitableforcertaininvestors.Eachinvestormust
makeitsowndeterminationastotheappropriatenessofanysecuritiesreferredtointhisresearchreportbaseduponthelegal,taxandaccountingconsiderations
applicable to such investor and its own investment objectives or strategy, its financial situation and its investing experience. The value of any security may be
positivelyoradverselyaffectedbychangesinforeignexchangeorinterestrates,aswellasbyotherfinancial,economicorpoliticalfactors.Pastperformanceisnot
necessarilyindicativeoffutureperformanceorresults.

Sources, Completeness and Accuracy: The material herein is based upon information obtained from sources that PCIPL and the research analyst believe to be
reliable, but neither PCIPL northe research analystrepresents or guarantees that the information contained herein is accurate or complete and it should not be
relieduponassuch.Opinionsexpressedhereinarecurrentopinionsasofthedateappearingonthismaterialandaresubjecttochangewithoutnotice.Furthermore,
PCIPLisundernoobligationtoupdateorkeeptheinformationcurrent.

Copyright:ThecopyrightinthisresearchreportbelongsexclusivelytoPCIPL.Allrightsarereserved.Anyunauthorizeduseordisclosureisprohibited.Noreprintingor
reproduction,inwholeorinpart,ispermittedwithoutthePCIPLspriorconsent,exceptthatarecipientmayreprintitforinternalcirculationonlyandonlyifitis
reprintedinitsentirety.

Caution: Riskoflossin tradingin canbe substantial.You should carefully consider whethertradingisappropriate foryouinlightofyourexperience,objectives,
financialresourcesandotherrelevantcircumstances.

PhillipCapital(India)Pvt.Ltd.
2ndFloor,CBlock,ModernCentre,Mahalaxmi,Mumbai400011

9of9

Anda mungkin juga menyukai